|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$15,379
|
Barr, Frederic
|
CCR (NCI)
|
|
ARF6 function in cancers driven by RAS hyperactivation
|
1K99CA230312-01
|
$129,824
|
$129,824
|
YOO, JAE HYUK
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$840
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$2,065
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$2,578
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
$1,250
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
$2,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
$2,486
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S4
|
$114,251
|
$1,143
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S5
|
$59,693
|
$597
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S6
|
$155,422
|
$1,554
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S7
|
$171,608
|
$1,716
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S8
|
$151,649
|
$1,516
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S9
|
$228,331
|
$2,283
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-29
|
$2,284,970
|
$22,850
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA091842-17S1
|
$240,897
|
$4,818
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S2
|
$254,917
|
$5,098
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S3
|
$199,999
|
$4,000
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S4
|
$124,730
|
$2,495
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-17
|
$4,207,812
|
$84,156
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$4,987
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cell of Origin and the Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics
|
2R01CA166593-06A1
|
$384,750
|
$384,750
|
LE, LU
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Clinical and Genetic Studies of Neurofibromatosis Type 1
|
ZIA CP010144 10567
|
$28,589
|
$28,589
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
|
2R42CA192600-02
|
$184,073
|
$184,073
|
WU, YIN
|
IQ MEDICAL IMAGING, LLC
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-53S1
|
$137,250
|
$13,726
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-53S2
|
$250,000
|
$25,000
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-53S3
|
$125,000
|
$12,500
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-53
|
$2,758,277
|
$275,828
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 10722
|
$362,499
|
$362,499
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
|
5R01CA214146-03
|
$348,844
|
$348,844
|
GUTMANN, DAVID
|
WASHINGTON UNIVERSITY
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-03
|
$235,046
|
$235,046
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing Human Induced Pluripotent Stem Cell Precision Oncology Models
|
1R50CA233164-01
|
$155,981
|
$155,981
|
ANASTASAKI, CORINA
|
WASHINGTON UNIVERSITY
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
$66,119
|
Beutler, John
|
CCR (NCI)
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-04
|
$2,102,055
|
$1,765,726
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
5R01CA111754-13
|
$316,635
|
$316,635
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Families at high risk of cancer
|
ZIA CP004410 08285
|
$76,748
|
$5,372
|
Savage, Sharon
|
DCEG (NCI)
|
|
Genomic dissection of tumor heterogeneity and progression
|
ZIA BC 011734
|
$391,418
|
$391,418
|
Shern, John
|
CCR (NCI)
|
|
Hodgkin's families
|
ZIA CP004410 08167
|
$69,137
|
$31,112
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
|
ZIA BC 011754
|
$727,056
|
$654,351
|
Reilly, Karlyne
|
CCR (NCI)
|
|
New Ways of Targeting K-Ras
|
5R35CA197709-03
|
$944,270
|
$472,135
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$865,625
|
$432,813
|
Glod, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
$692,500
|
Glod, John
|
CCR (NCI)
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
5R01CA201130-03
|
$401,040
|
$401,040
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$602,021
|
$120,404
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of STE20 protein kinases in malignant mesothelioma
|
5R01CA148805-08
|
$434,625
|
$434,625
|
CHERNOFF, JONATHAN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$553,334
|
$44,267
|
Trepel, Jane
|
CCR (NCI)
|
|
Targeting the Kinome in Neurofibromatosis type 1
|
5R01CA142928-09
|
$434,625
|
$434,625
|
CHERNOFF, JONATHAN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$4,314
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
Total relevant funding to Neurofibromatosis for this search: $9,687,405
|